Protease inhibitors: resistance, resistance, resistance.

Abstract excerpt

Current anti-HIV drugs are plagued by problems with development of resistance. Reports at the 4th Annual Conference on Retroviruses and Opportunistic Infections proposed various ways to use protease inhibitor-containing combinations to build a high enough genetic barrier against HIV breakthrough. Two studies confirmed that potent highly active antiretroviral therapy combination therapies can be beneficial even to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV Infections
• Share to Viral Load
• Share to HIV Protease Inhibitors